Inmune Bio, Inc.
For the period ended Jun 16, 2026. Filed Apr 23, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 16, 2026 · Filed Apr 23, 2026
Contents
Cover page
Show cover page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
| Filed by the Registrant | ☒ |
|---|---|
| Filed by a Party other than the Registrant | ☐ |
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
|---|---|
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☒ | Definitive Proxy Statement |
| ☐ | Definitive Additional Materials |
| ☐ | Soliciting Material under §240.14a-12 |
INMUNE BIO INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ☒ | No fee required. |
|---|---|
| ☐ | Fee paid previously with preliminary materials. |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
INMUNE BIO INC.
225 NE Mizner Blvd, Suite 640, Boca Raton, FL 33432
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ONJune 16, 2026
AT 10:00 A.M. EASTERN TIME
TO THE STOCKHOLDERS OF INMUNE BIO INC.:
The annual meeting of stockholders (the “Meeting”) of INmune Bio Inc. (which we refer to as “INmune” or the “Company”) will be a completely virtual meeting of stockholders.
To participate, vote, or submit questions 15 minutes before and duringthe Meeting via live webcast, please visit www.virtualshareholdermeeting.com/INMB2026There will not be a physical location for the Meeting.
At the Meeting, the holders of the Company’s outstanding capital stock will act on the following matters:
To elect five directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified;
To ratify the appointment of CBIZ CPAs P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2026; and
To approve the Third Amended and Restated INmune Bio Inc. 2021 Stock Incentive Plan.
We also will transact such other business as may properly come before the Meeting and any adjournments or postponements of the Meeting.
These matters are more fully described in the proxy statement accompanying this notice.
Only holders of the Company’s common stock of record at the close of business on April 20, 2026, are entitled to notice of and to vote at the Meeting. A proxy statement containing important information about the Meeting and the matters voted upon appear on the following pages.
The Board of Directors recommends that you vote “FOR” the proposals set forth in this Notice of Annual Meeting of Stockholders and the proxy statement.
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING
The Company has enclosed a copy of the proxy statement, the proxy card and the Company’s annual report, as amended to stockholders for the year ended December 31, 2025 (the “Annual Report”). The proxy statement, the proxy card and the Annual Report are also available on the Company’s website athttps://www.inmunebio.com/index.php/investors/sec-filings.
If you have any questions or need assistance voting your shares of our common stock, please contact the Company at (561) 710-0512.
/s/ David Moss
David Moss
Chief Executive Officer and Secretary
Boca Raton, FL
April 23, 2026
PLEASE NOTE: The Meeting will be held to tabulate the votes cast and to report the results of voting on the items described above. No other business matters are planned for the Meeting.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.